Journal of Foot and Ankle Surgery
Volume 48, Issue 6 , Pages 690.e1-690.e5 , November 2009

The Dot-in-Circle Sign in Madura Foot

  • Lee Parker, BM, MRCS

      Affiliations

    • Specialist Registrar Trauma and Orthopaedic Surgery, Royal National Orthopaedic Hospital, Middlesex, UK
    • Corresponding Author InformationAddress correspondence to: Lee Parker MRCS, Royal National Orthopaedic Hospital, Brockley Hill, Stanmore, Middlesex, UK HA7 4LP.
    • ,
  • Dishan Singh, FRCS (Orth)

      Affiliations

    • Consultant Orthopaedic Surgeon, Royal National Orthopaedic Hospital, Middlesex, UK
    • ,
  • Carlo Biz, MD

      Affiliations

    • Orthopaedic Resident, Padua University Orthopaedic and Trauma Clinic, Padova, Italy

References 

  1. Sarris I, Berendt AR, Athanasous N, Ostlere SJ. MRI of mycetoma of the foot: two cases demonstrating the dot-in-circle sign. Skeletal Radiol. 2003;32:179–183
  2. Godfrey G. Diseases of the foot not hitherto described. Lancet I. 1946;593–594
  3. Carter HV. On a new and striking form of fungus disease, principally affecting the foot and prevailing endemically in many parts of India. Trans Med Phys Soc Bombay. 1860;6:104–142
  4. Fahal AH, Hassan MA. Mycetoma. Br J Surg. 1992;79:1138–1141
  5. Magana M. Mycetoma. Int J Dermatol. 1984;23:221–236
  6. Van de Sande WWJ, de Kat J, Coppens J, Ahmed AOA, Fahal A, Verbrugh H, et al. Melanin biosynthesis in Madurella mycetomatis and its effect on susceptibility to itraconazole and ketoconazole. Microbes Infection. 2007;9(9):1114–1123
  7. Daoud M, Ezzine Sebai N, Badri T, Mokhtar I, Fazza B, Kamoun MR. Mycetoma: retrospective study of 13 cases in Tunisia. Acta Dermatoven APA. 2005;14(4):153–156
  8. De Palma L, Marinelli M, Pavan M, Manso E, Ranaldi R. A rare European case of Madura foot due to actinomycetes. Joint Bone Spine. 2006;73(3):321–334
  9. Ahmed AOA, van Leeuwen W, Fahal A, van de Sande W, Verbrugh H, van Belkum A. Mycetoma caused by Madurella mycetomatis: a neglected infectious burden. Lancet Infectious Diseases. 2004;4(9):566–574
  10. Fahal AH, Sheik HE, Homeida MMA, Arabi YE, Mahgoub ES. Ultrasonographic imaging of mycetoma. Br J Surg. 1997;84:1120–1122
  11. El Hag IA, Fahal AH, Gasmin ETA. Fine needle aspiration cytology of mycetoma. Acta Cytol. 1996;40:461–464
  12. McGinnis MR. Mycetoma. Dermatol Clin. 1996;14:97–104
  13. Fahal ah, El Hassan MA, Sanhouri M. Surgical treatment of mycetoma. Sudan Med J. 1994;32:92–104
  14. Ahmed AOA, van de Sande WWJ, van Vianen W, van Belkum A, Fahal AH, Verbrugh HA, et al. In vitro susceptibilities of Madurella mycetomatis to itraconazole and amphotericin B assessed by a modified NCCLS method and a viability-based 2,3-Bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay. Antimicrob Agents Chemother. 2004;48(7):2742–2746
  15. Fahal AH. Mycetoma updates. Online review article, Mycetoma Research Centre, University of Khartoum, Sudan. Available at: http://www.mycetoma.edu.sd/academic/updates.htm#EumycetomaMedicalTreatment Accessed April 8, 2009.
  16. Year H, Bourgnoux ME, Jeanrot C, Baixench MT, De Pinieux G, Dupouy-Camet J. Mycetoma of the foot caused by Fusarium solani: identification of the etiologic agent by DNA sequencing. J Clin Microbiol. 2003;41(4):1805–1808
  17. Desnos-Ollivier M, Bretagne S, Dromer F, Lortholary O, Dannaoui E. Molecular identification of black-grain mycetoma agents. J Clin Microbiol. 2006;44(10):3517–3523

 Financial Disclosure: None reported.

 Conflict of Interest: None reported.

PII: S1067-2516(09)00293-2

doi: 10.1053/j.jfas.2009.07.007

Journal of Foot and Ankle Surgery
Volume 48, Issue 6 , Pages 690.e1-690.e5 , November 2009

Article Tools

* Image Usage & Resolution